EuroFlow Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

EuroFlow General Information

Description

Developer of flow cytometric tests designed to improve the quality of diagnostics in the field of hemato-oncology worldwide. The company develops standardized flow cytometry protocols and operating procedures and conducts educational workshops, enabling medical experts to evaluate their whole flow cytometric analysis process and obtain a certificate for good performance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Dreef 6th Floor
  • 7202 AG Zutphen
  • Netherlands
Primary Industry
Diagnostic Equipment
Corporate Office
  • Dreef 6th Floor
  • 7202 AG Zutphen
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EuroFlow Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Dec-2022 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view EuroFlow’s complete valuation and funding history, request access »

EuroFlow FAQs

  • When was EuroFlow founded?

    EuroFlow was founded in 2005.

  • Where is EuroFlow headquartered?

    EuroFlow is headquartered in Zutphen, Netherlands.

  • What industry is EuroFlow in?

    EuroFlow’s primary industry is Diagnostic Equipment.

  • Is EuroFlow a private or public company?

    EuroFlow is a Private company.

  • What is EuroFlow’s current revenue?

    The current revenue for EuroFlow is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process